Anika Therapeutics (ANIK) Interest Coverage Ratio Growth (1y) (2019 - 2025)
Anika Therapeutics (ANIK) Interest Coverage Ratio Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.64 Bn | 87.78 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 22.98 Bn | 20.83 Bn | 648.10 Mn | -58.34% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | -14.91% |
| 10 | Anika Therapeutics | 203.78 Mn | 136.99 Mn | 19.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,137,065.67% |
| Jun 30, 2025 | -69,181.77% |
| Dec 31, 2024 | -100.01% |
| Sep 30, 2024 | 90.21% |
| Jun 30, 2024 | -99.39% |
| Mar 31, 2024 | 60.09% |
| Sep 30, 2023 | -442.14% |
| Jun 30, 2023 | -174.39% |
| Mar 31, 2023 | 94.97% |
| Sep 30, 2022 | -320.33% |
| Mar 31, 2022 | -7,005.85% |
| Dec 31, 2021 | 215.49% |
| Sep 30, 2021 | 101.76% |
| Mar 31, 2021 | 599.74% |
| Dec 31, 2020 | -472.37% |
| Sep 30, 2020 | -366.32% |
| Jun 30, 2020 | -456.02% |
| Mar 31, 2020 | 44.71% |
| Dec 31, 2019 | 65.15% |